Science Explorer Back to mapMap
Institution · Porsolt (France)

Most cited papers from Porsolt (France)

What are the most cited papers from Porsolt (France)?

The most cited paper from Porsolt (France) is "Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice" (Vincent Castagné, Paul C. Moser, Sylvain Roux et al., 2011), with 700 citations. Next come "Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors" (224) and "Rodent Models of Depression: Forced Swimming and Tail Suspension Behavioral Despair Tests in Rats and Mice" (212).

Showing 50 of 58 papers. Every paper with more than 12 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Rodent Models of Depression: Forced Swim and Tail Suspension Behavioral Despair Tests in Rats and Mice Vincent Castagné, Paul C. Moser, Sylvain Roux et al. · Current Protocols in Neuroscience Apr 2011 700
2 Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors Michel Bourin, Elisabeth Mocaër, Roger D. Porsolt · Journal of Psychiatry and Neuroscience Open access Mar 2004 224
3 Rodent Models of Depression: Forced Swimming and Tail Suspension Behavioral Despair Tests in Rats and Mice Roger D. Porsolt, Geneviève Brossard, Carine Hautbois et al. · Current Protocols in Neuroscience Feb 2001 212
4 Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse Vincent Castagné, Roger D. Porsolt, Paul C. Moser · European Journal of Pharmacology 22 Jun 2009 153
5 Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs Nadia M.J. Rupniak, Emma J. Carlson, J.K. Webb et al. · Behavioural Pharmacology Nov 2001 150
6 Primary Observation (Irwin) Test in Rodents for Assessing Acute Toxicity of a Test Agent and its Effects on Behavior and Physiological Function Sylvain Roux, Evelyne Sablé, Roger D. Porsolt · Current Protocols in Pharmacology Dec 2004 126
7 Behavioral Indices in Antipsychotic Drug Discovery Roger D. Porsolt, Paul C. Moser, Vincent Castagné · Journal of Pharmacology and Experimental Therapeutics 4 Mar 2010 99
8 Brain and hippocampus fatty acid composition in phospholipid classes of aged-relative cognitive deficit rats Lionel Ulmann, Virginie Mimouni, Sylvain Roux et al. · Prostaglandins Leukotrienes and Essential Fatty Acids Mar 2001 91
9 Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies James J. Lynch, Vincent Castagné, Paul C. Moser et al. · Journal of Pharmacological and Toxicological Methods 14 Mar 2011 90
10 The role of the entorhinal cortex in two forms of spatial learning and memory David M. Bannerman, Yee B., Lemaire M. et al. · Experimental Brain Research Dec 2001 83
11 New perspectives in CNS safety pharmacology Roger D. Porsolt, Martine Lemaire‐Chamley, Niklaus Dürmüller et al. · Fundamental and Clinical Pharmacology Jun 2002 83
12 Effects of cannabinoid receptor ligands on psychosis-relevant behavior models in the rat Renée S. Martin, Robert L. Secchi, Eric Sung et al. · Psychopharmacology 2003 82
13 Introduction to the EQIPD quality system Anton Bespalov et al. · eLife Open access 24 May 2021 78
14 Combined Therapeutic Strategy Using Erythropoietin and Mesenchymal Stem Cells Potentiates Neurogenesis after Transient Focal Cerebral Ischemia in Rats Elise Esneault, Emilie Pacary, Dauphou Eddi et al. · Journal of Cerebral Blood Flow & Metabolism 14 May 2008 73
15 The Serotonin1A Receptor Partial Agonist S15535 [4-(Benzodioxan-5-yl)1-(indan-2-yl)piperazine] Enhances Cholinergic Transmission and Cognitive Function in Rodents: A Combined Neurochemical and Behavioral Analysis Mark J. Millan, Alain P. Gobert, Sylvain Roux et al. · Journal of Pharmacology and Experimental Therapeutics 16 Sep 2004 70
16 Cytotoxic lesions of the hippocampus increase social investigation but do not impair social-recognition memory David M. Bannerman, M. Lemaire, Simon A. S. Beggs et al. · Experimental Brain Research 17 Apr 2001 70
17 Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response Tristan Rupp, Laurie Genest, David Babin et al. · Translational Oncology Open access 25 Mar 2022 69
18 Preclinical Behavioral Models for Predicting Antipsychotic Activity Vincent Castagné, Paul C. Moser, Roger D. Porsolt · Advances in pharmacology Book chapter 2009 61
19 D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats Elise Esneault, Vincent Castagné, Paul C. Moser et al. · Neuroscience 7 Jan 2008 57
20 Selective cytotoxic lesions of the retrohippocampal region produce a mild deficit in social recognition memory David M. Bannerman, Lemaire M., Yee B. et al. · Experimental Brain Research Feb 2002 57
21 Blinding and Randomization Anton Bespalov, Karsten M. Wicke, Vincent Castagné · Handbook of experimental pharmacology Book chapterOpen access 2019 55
22 The preclinical pharmacologic profile of tiapride B. Scatton, Caroline Cohen, Ghislaine Perrault et al. · European Psychiatry 2001 52
23 Endothelin-Converting Enzyme/Neutral Endopeptidase Inhibitor SLV338 Prevents Hypertensive Cardiac Remodeling in a Blood Pressure–Independent Manner Philipp Kalk, Yuliya Sharkovska, Elena V. Kashina et al. · Hypertension 22 Feb 2011 41
24 Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk Pierre Lacroix, William Crumb, Lucia Durando et al. · European Journal of Pharmacology Sep 2003 40
25 The use of the dog electroencephalogram (EEG) in safety pharmacology to evaluate proconvulsant risk Niklaus Dürmüller, Philippe Guillaume, Pierre Lacroix et al. · Journal of Pharmacological and Toxicological Methods 25 May 2007 36
26 C57BL/6 mice as a preclinical model to study age-related cognitive deficits: Executive functions impairment and inter-individual differences Al Mahdy Hamieh, Emmanuelle Camperos, Anne Marie Hernier et al. · Brain Research 23 Oct 2020 35
27 Contextual fear conditioning is disrupted by lesions of the subcortical, but not entorhinal, connections to the hippocampus David M. Bannerman, Yee B., Lemaire M. et al. · Experimental Brain Research Dec 2001 34
28 How Good Are Current Approaches to Nonclinical Evaluation of Abuse and Dependence? Paul C. Moser, Toni D. Wolinsky, Mark S. Duxon et al. · Journal of Pharmacology and Experimental Therapeutics 23 Nov 2010 33
29 OBE022, an Oral and Selective Prostaglandin F2 Receptor Antagonist as an Effective and Safe Modality for the Treatment of Preterm Labor Oliver Pohl, André Chollet, Sung Hye Kim et al. · Journal of Pharmacology and Experimental Therapeutics Open access 18 May 2018 31
30 Therapeutic potential of Fingolimod in triple negative breast cancer preclinical models Tristan Rupp, Océane Pelouin, Laurie Genest et al. · Translational Oncology Open access 3 Nov 2020 29
31 Models of Affective Illness: Forced Swimming and Tail Suspension Tests in Rodents Roger D. Porsolt, Geneviève Brossard, Carine Hautbois et al. · Current Protocols in Pharmacology Sep 2000 28
32 Face-to-face comparison of the predictive validity of two models of neuropathic pain in the rat: Analgesic activity of pregabalin, tramadol and duloxetine Camille Le Cudennec, Vincent Castagné · European Journal of Pharmacology 12 Apr 2014 27
33 Current approaches and issues in non-clinical evaluation of abuse and dependence Paul C. Moser, Toni D. Wolinsky, Vincent Castagné et al. · Journal of Pharmacological and Toxicological Methods 23 Sep 2010 27
34 The proconvulsant effects of leptin on glutamate receptor-mediated seizures in mice James J. Lynch, Eugene W. Shek, Vincent Castagné et al. · Brain Research Bulletin 11 Feb 2010 26
35 Antibodies to S100 proteins have anxiolytic-like activity at ultra-low doses in the adult rat Vincent Castagné, Martine Lemaire‐Chamley, I. A. Kheyfets et al. · Journal of Pharmacy and Pharmacology 13 Feb 2008 25
36 Memory Disorders Related to Hippocampal Function: The Interest of 5-HT4Rs Targeting Candice M. Roux, Marianne Léger, Thomas Fréret · International Journal of Molecular Sciences Open access 8 Nov 2021 24
37 Early behavioral screening for antidepressants and anxiolytics Vincent Castagné, Roger D. Porsolt, Paul C. Moser · Drug Development Research Sep 2006 24
38 Interplay between 5-HT4 Receptors and GABAergic System within CA1 Hippocampal Synaptic Plasticity Pierre Lecouflet, Candice M. Roux, Brigitte Potier et al. · Cerebral Cortex 14 Aug 2020 23
39 Continuous evaluation of drug withdrawal in the rat using telemetry: Effects of morphine and chlordiazepoxide Christelle Froger-Colléaux, Sonia Rompion, Philippe Guillaume et al. · Journal of Pharmacological and Toxicological Methods 14 Mar 2011 23
40 The usefulness of non-human primates in central nervous system safety pharmacology Roger D. Porsolt · Journal of Pharmacological and Toxicological Methods 19 Mar 2013 23
41 Central Nervous System (CNS) Safety Pharmacology Studies Vincent Castagné, Christelle Froger-Colléaux, Elise Esneault et al. Book chapter 2013 23
42 Ventilatory function assessment in safety pharmacology: Optimization of rodent studies using normocapnic or hypercapnic conditions Sonia Goineau, Sonia Rompion, Philippe Guillaume et al. · Toxicology and Applied Pharmacology 21 Jun 2010 22
43 International safety pharmacology guidelines (ICH S7A and S7B): where do we go from here? Roger D. Porsolt, Sandra Picard, Pierre Lacroix · Drug Development Research Feb 2005 22
44 Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers Sonia Goineau, Vincent Castagné · Journal of Pharmacological and Toxicological Methods 20 Dec 2017 19
45 Comparison of three preclinical models for nausea and vomiting assessment Sonia Goineau, Vincent Castagné · Journal of Pharmacological and Toxicological Methods 29 Jul 2016 19
46 Differential behavioral profiling of stimulant substances in the rat using the LABORAS™ system Vincent Castagné, Toni D. Wolinsky, Leann P. Quinn et al. · Pharmacology Biochemistry and Behavior 9 Mar 2012 19
47 Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats Colleen Synan, Carrie A. Bowen, David J. Heal et al. · Drug and Alcohol Dependence Open access 30 Dec 2021 17
48 Overview of Safety Pharmacology Sonia Goineau, Martine Lemaire‐Chamley, Guillaume Froget · Current Protocols in Pharmacology Dec 2013 16
49 Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models Tristan Rupp, Solène Debasly, Laurie Genest et al. · International Journal of Molecular Sciences Open access 25 Jul 2022 15
50 A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity Tristan Rupp, Christophe Legrand, Marion Hunault et al. · Cancers Open access 21 Jul 2022 15

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.